Evidence map›Paper›PMID 40739111›Full record

ArticleScientific reports2025

Retrospective analysis of primary pulmonary lymphoma cases from Polish Lymphoma Research Group centers reveals associations between initial symptoms and outcomes.

Agnieszka Giza, Paulina Dumnicka, Elżbieta Kalicińska, Joanna Romejko-Jarosińska, Joanna Drozd-Sokołowska, Aleksander Kania, Dagmara Zimowska-Curyło, Wanda Knopińska-Posłuszny, Grażyna Siewior, Renata Guzicka-Kazimierczak and 10 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Agnieszka GizaDepartment of Hematology, Jagiellonian University Medical College, Faculty of Medicine, Jakubowskiego 2, 30-688, Kraków, Poland.
Paulina DumnickaChair of Medical Biochemistry, Faculty of Medicine, Jagiellonian University Medical College, Kopernika 7, 31-034, Kraków, Poland. paulina.dumnicka@uj.edu.pl.
Elżbieta KalicińskaDepartament of Hematology, Cellular Therapies and Internal Medicine, Medical University, Wroclaw, Pasteura 4, 50-367, Wrocław, Poland.
Joanna Romejko-JarosińskaDepartment of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Wilhelma Konrada Roentgena 5, 02-781, Warsaw, Poland.
Joanna Drozd-SokołowskaDepartment of Hematology, Transplantation and Internal Medicine, University Clinical Centre, Medical University of Warsaw, Stefana Banacha 1a, 02-097, Warsaw, Poland.
Aleksander Kania2nd Department of Medicine, Department of Pulmonology Jagiellonian University Medical College, Faculty of Medicine, Jakubowskiego 2, 30- 688, Kraków, Poland.
Dagmara Zimowska-CuryłoDepartment of Hematology, Jagiellonian University Medical College, Faculty of Medicine, Jakubowskiego 2, 30-688, Kraków, Poland.
Wanda Knopińska-PosłusznyDepartment of Hematology and Bone Marrow Transplantation, Maritime Hospital, Powstania Styczniowego 1, 81-519, Gdynia, Poland.
Grażyna SiewiorInternal Medicine and Oncology Department, Medical University of Silesia, Reymonta 8, 40-029, Katowice, Poland.
Renata Guzicka-KazimierczakDepartment Hematology and Transplantology, Pomeranian Medical University, Unii Lubelskiej 1, 71-242, Szczecin, Poland.
Magdalena WitkowskaDepartment of Hematology, Medical University of Lodz, Ciolkowskiego 2, 93-513, Lodz, Poland.
Marta MorawskaExperimental Hematooncology Department, Medical University of Lublin, Witolda Chodźki 1, 20-400, Lublin, Poland.
Paweł KurczabMrukmed Medical Center with Outpatient Chemotherapy Unit, Langiewicza 61, 35-922, Rzeszow, Poland.
Ewa KalinkaDepartment of Oncology, Polish Mother's Memorial Hospital-Research Institute in Lodz, Rzgowska 281/289, 93-338, Lodz, Poland.
Marta HandzlikBeskid Oncology Center - City Hospital in Bielsko-Biała, Wyzwolenia 18, 43-300, Bielsko-Biała, Poland.
Dariusz GizaDepartment of Nephrology, Jagiellonian University Medical College, Faculty of Medicine, Jakubowskiego 2, 30-688, Kraków, Poland.
Ewa Paszkiewicz-KozikDepartment of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Wilhelma Konrada Roentgena 5, 02-781, Warsaw, Poland.
Sebastian GiebelDepartment of Bone Marrow Transplantation and Oncohematology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101, Gliwice, Poland.
Jan Maciej ZauchaDepartment of Hematology and Transplantology, Medical University of Gdańsk, Faculty of Medicine and University Clinical Center, Smoluchowskiego 17, 80-213, Gdańsk, Poland.
Tomasz WróbelDepartament of Hematology, Cellular Therapies and Internal Medicine, Medical University, Wroclaw, Pasteura 4, 50-367, Wrocław, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary pulmonary lymphoma (PPL) is a rare extranodal lymphoma, accounting for only 0.4% of all lymphomas. We conducted a retrospective analysis of 78 patients with PPL treated at 15 tertiary care hematooncology centers in Poland. The study revealed a high incidence of aggressive B-cell lymphoma (42%), although this may reflect the specificity of participating centers. A high prevalence of pleural effusion and dyspnea at the time of diagnosis was found to be associated with worse overall survival in all PPL patients. Dyspnea and bilateral lung lesions at presentation were associated with a lack of complete remission, while the presence of cough was associated with shorter time to disease progression or relapse. Although the progression-free survival did not differ significantly between patients with low- versus high-grade B-cell PPLs, those with indolent PPLs exhibited superior overall survival. To the best of our knowledge, this study is the first multicenter retrospective analysis of PPL in Central Europe involving such a large cohort of patients.

Indexed as

Lung NeoplasmsLymphomaAdultAgedAged, 80 and overDyspneaFemaleHumansMaleMiddle AgedPolandRetrospective StudiesAggressive B-cell lymphomaExtranodal lymphomaNon-Hodgkin lymphomaPrimary pulmonary lymphoma

Identifiers

PMID40739111
PMCPMC12311183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.